410 related articles for article (PubMed ID: 25850749)
41. Angiotensin System Blockade Combined With Calcium Channel Blockers Is Superior to Other Combinations in Cardiovascular Protection With Similar Blood Pressure Reduction: A Meta-Analysis in 20,451 Hypertensive Patients.
Chi C; Tai C; Bai B; Yu S; Karamanou M; Wang J; Protogerou A; Blacher J; Safar ME; Zhang Y; Xu Y
J Clin Hypertens (Greenwich); 2016 Aug; 18(8):801-8. PubMed ID: 26778747
[TBL] [Abstract][Full Text] [Related]
42. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
43. Optimizing the pharmacologic treatment of hypertension: BP control and target organ protection.
Nilsson PM
Am J Cardiovasc Drugs; 2006; 6(5):287-95. PubMed ID: 17083263
[TBL] [Abstract][Full Text] [Related]
44. Calcium antagonists in antihypertensive combination therapy.
Hansson L; Himmelmann A
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S76-80. PubMed ID: 1725010
[TBL] [Abstract][Full Text] [Related]
45. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
46. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
[TBL] [Abstract][Full Text] [Related]
48. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
49. Current recommendations for the treatment of hypertension: are they still valid?
Moser M
J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
[TBL] [Abstract][Full Text] [Related]
50. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
[TBL] [Abstract][Full Text] [Related]
51. Novel combinations in the treatment of hypertension.
Sica DA
Minerva Urol Nefrol; 2005 Sep; 57(3):129-39. PubMed ID: 15986012
[TBL] [Abstract][Full Text] [Related]
52. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
53. Hypertension management: rationale for triple therapy based on mechanisms of action.
Neutel JM; Smith DH
Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
[TBL] [Abstract][Full Text] [Related]
54. Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations.
de la Sierra A; Banegas JR; Vinyoles E; Gorostidi M; Segura J; de la Cruz JJ; Ruilope LM
Clin Exp Hypertens; 2016; 38(4):409-14. PubMed ID: 27159660
[TBL] [Abstract][Full Text] [Related]
55. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
56. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
Taddei S; Ghiadoni L; Salvetti A
Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
[TBL] [Abstract][Full Text] [Related]
57. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
[TBL] [Abstract][Full Text] [Related]
58. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
59. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
60. Combination therapy in hypertension.
Cappuccio FP; MacGregor GA
J Hum Hypertens; 1991 Dec; 5 Suppl 2():9-14; discussion 14-5. PubMed ID: 1686467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
